Leadership Overview
Boehringer Ingelheim has 10 executives leading key functions including finance, strategy, marketing, information technology, and operations.
Driven by a commitment to innovation, Boehringer Ingelheim focuses on developing life-changing medicines and healthcare products, impacting human and animal health globally through dedicated research and development.
Driven by a commitment to innovation, Boehringer Ingelheim focuses on developing life-changing medicines and healthcare products, impacting human and animal health globally through dedicated research and development.
Leadership Roles at Boehringer Ingelheim
Jean-Michel Boers - President & Chief Executive Officer (USA)
Jean-Michel Boers, the President & Chief Executive Officer (USA) at Boehringer Ingelheim, directs the company's comprehensive operations and strategic vision within the United States market. Boers leads the executive team in driving growth, innovation, and market leadership across Boehringer Ingelheim's key business areas, including Human Pharma and Animal Health. His responsibilities encompass overseeing all commercial, research, and operational functions within the U.S., ensuring alignment with global corporate objectives and fostering a culture of scientific excellence and patient-centricity. Jean-Michel Boers' leadership is critical in navigating the dynamic U.S. healthcare landscape, advancing the development and accessibility of groundbreaking medicines. The President & Chief Executive Officer (USA) champions strategic initiatives that enhance Boehringer Ingelheim's impact on public health and veterinary care, solidifying its position as a leading pharmaceutical innovator. Boers' strategic direction guides the U.S. entity towards sustained success and contribution to global health outcomes.
Jean Mauldin - Chief Financial Officer
Jean Mauldin, the Chief Financial Officer at Boehringer Ingelheim, directs the company's global financial strategy and operations. Overseeing all fiscal activities, Mauldin ensures robust financial planning, accurate reporting, and effective capital allocation across the organization's diverse business units, including Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. This leadership role involves managing budgets, optimizing financial performance, and driving profitability in alignment with Boehringer Ingelheim's long-term research and development objectives. Jean Mauldin's financial acumen supports the company's private ownership structure and its commitment to sustained investment in innovation. The Chief Financial Officer's oversight extends to risk management and ensuring compliance with international financial regulations, safeguarding the company's financial integrity and supporting its expansion into new therapeutic areas and global markets. Mauldin's strategic financial guidance is critical for maintaining Boehringer Ingelheim's position as a leading privately held pharmaceutical entity.
Cesar Redondo - Director, Finance Administration & Chief Financial Officer
Cesar Redondo, the Director, Finance Administration & Chief Financial Officer at Boehringer Ingelheim, manages critical financial administration functions and supports the overall Chief Financial Officer's strategic directives. Redondo's responsibilities encompass the operational aspects of financial administration, ensuring the smooth execution of daily financial processes and maintaining the integrity of financial systems. This role is vital for supporting the company's extensive operations across more than 100 countries, facilitating seamless financial transactions and reporting. Cesar Redondo's focus on administrative efficiency complements the broader financial strategy, enabling Boehringer Ingelheim to allocate resources effectively towards its research-driven pharmaceutical endeavors. The Director, Finance Administration & Chief Financial Officer ensures that administrative financial controls are robust, supporting the company's commitment to ethical business practices and its mission to develop innovative medicines. Redondo's contribution is key to the operational stability that underpins Boehringer Ingelheim's global presence and its dedication to advancing human and animal health.
Eduardo Macedo - Head of Sustainability, Strategy & Operations To Cmd Chief of Staff
Eduardo Macedo, the Head of Sustainability, Strategy & Operations To Cmd Chief of Staff at Boehringer Ingelheim, drives integrated strategic initiatives and operational excellence with a strong focus on sustainability. Macedo's role bridges corporate strategy, operational execution, and the critical imperative of environmental and social responsibility, aligning these with the Chief of Staff's office. This position is instrumental in shaping Boehringer Ingelheim's long-term vision, ensuring that strategic planning incorporates sustainable practices across its pharmaceutical and animal health businesses. Eduardo Macedo oversees operational frameworks that support efficient research, development, and manufacturing, while simultaneously embedding sustainability principles into the company's core functions. The Head of Sustainability, Strategy & Operations To Cmd Chief of Staff champions initiatives that reduce environmental impact and enhance social value, reinforcing Boehringer Ingelheim's commitment to responsible corporate citizenship. Macedo's leadership ensures that strategic growth is achieved in harmony with global sustainability goals.
Sherry Gu - Director-Asia Strategic Partnership and Chief Marketing Officer Management
Sherry Gu, the Director-Asia Strategic Partnership and Chief Marketing Officer Management at Boehringer Ingelheim, spearheads critical strategic partnerships within the Asian market and oversees Chief Marketing Officer management functions. Gu's role is pivotal in cultivating and managing alliances that drive business growth and market penetration across diverse Asian economies, supporting Boehringer Ingelheim's global expansion. This involves identifying key collaborators and negotiating agreements that align with the company's pharmaceutical and animal health objectives. Sherry Gu's leadership in Chief Marketing Officer management ensures cohesive marketing strategies and brand consistency across the region, optimizing promotional efforts and market engagement. The Director-Asia Strategic Partnership and Chief Marketing Officer Management plays a crucial part in navigating the complex regulatory and commercial landscapes of Asia, fostering innovation and access to Boehringer Ingelheim's products. Gu's strategic vision strengthens the company's presence and impact in this vital global region.
Vicky Kostman - Senior Principal Specialist, GIQA (GCP, GLP, GMP), (DMSO) Supplier Qualification and Chief Marketing Officer
Vicky Kostman, the Senior Principal Specialist, GIQA (GCP, GLP, GMP), (DMSO) Supplier Qualification and Chief Marketing Officer at Boehringer Ingelheim, brings a unique dual focus to quality assurance and marketing leadership. Kostman's expertise in Good Clinical Practice (GCP), Good Laboratory Practice (GLP), and Good Manufacturing Practice (GMP) ensures rigorous adherence to quality standards across the company's research, development, and manufacturing operations, particularly within the DMSO (Dimethyl sulfoxide) supplier qualification domain. This critical role safeguards the integrity and compliance of Boehringer Ingelheim's pharmaceutical products. Concurrently, as Chief Marketing Officer, Vicky Kostman drives strategic marketing initiatives, translating scientific advancements into compelling market narratives and ensuring effective product positioning. The Senior Principal Specialist, GIQA (GCP, GLP, GMP), (DMSO) Supplier Qualification and Chief Marketing Officer bridges technical quality oversight with market-facing strategies, ensuring both product excellence and commercial success for Boehringer Ingelheim's innovative therapies.
Alexander Guntur - Chief Information Officer, Advisory & Board Member
Alexander Guntur, the Chief Information Officer, Advisory & Board Member at Boehringer Ingelheim, provides strategic leadership and oversight for the company's global information technology infrastructure and digital transformation initiatives. Guntur's role involves architecting and implementing robust IT strategies that support Boehringer Ingelheim's complex research, development, manufacturing, and commercial operations across its Human Pharma and Animal Health divisions. As an Advisory and Board Member, Alexander Guntur offers critical insights into technology trends and their potential impact on the pharmaceutical industry, guiding the company's long-term digital roadmap. The Chief Information Officer, Advisory & Board Member ensures the security, scalability, and efficiency of IT systems, enabling data-driven decision-making and fostering innovation. Guntur's leadership is essential for leveraging technology to accelerate drug discovery, optimize supply chains, and enhance customer engagement, positioning Boehringer Ingelheim at the forefront of digital innovation in healthcare.
Unnati Bose - Chief of Staff. MD's Office
Unnati Bose, the Chief of Staff. MD's Office at Boehringer Ingelheim, provides strategic support and operational coordination for the Managing Director's office, ensuring alignment across key initiatives and stakeholder engagement. Bose's role is crucial in managing the MD's priorities, facilitating communication between the MD and various departments, and driving the execution of strategic projects. This involves streamlining operations, optimizing workflows, and ensuring that critical business objectives are met efficiently. Unnati Bose acts as a key liaison, bridging executive leadership with functional teams to foster collaboration and drive progress in areas such as Human Pharma and Animal Health. The Chief of Staff. MD's Office plays an integral part in enhancing organizational effectiveness and supporting the strategic direction set by the Managing Director. Bose's proactive approach and operational acumen are vital for the smooth functioning of the MD's office and the overall success of Boehringer Ingelheim's global operations.
Shawn Fosnaugh - Chief Marketing Officer, Operations & Manager
Shawn Fosnaugh, the Chief Marketing Officer, Operations & Manager at Boehringer Ingelheim, leads integrated marketing strategies and oversees operational aspects of marketing execution. Fosnaugh's role combines strategic market development with hands-on management of marketing campaigns and initiatives across Boehringer Ingelheim's diverse portfolio, including Human Pharma and Animal Health. This dual focus ensures that marketing efforts are not only innovative and impactful but also operationally sound and efficiently delivered. Shawn Fosnaugh drives brand visibility, market penetration, and customer engagement by developing and implementing comprehensive marketing plans. The Chief Marketing Officer, Operations & Manager is responsible for optimizing marketing resource allocation and ensuring alignment with business objectives, contributing significantly to revenue growth and market share expansion. Fosnaugh's leadership ensures that Boehringer Ingelheim's therapeutic innovations reach their intended audiences effectively.
Carolina Anjos - Chief of Staff for the Human Pharma Member of the Board
Carolina Anjos, the Chief of Staff for the Human Pharma Member of the Board at Boehringer Ingelheim, provides dedicated strategic and operational support to the Human Pharma Board Member. Anjos plays a pivotal role in coordinating activities, managing communications, and driving key initiatives within the Human Pharma division, ensuring seamless alignment with the Board's strategic objectives. This involves facilitating information flow, preparing critical documentation, and supporting decision-making processes at the highest level. Carolina Anjos's responsibilities extend to overseeing project execution and ensuring that strategic priorities are translated into actionable plans. The Chief of Staff for the Human Pharma Member of the Board acts as a key facilitator, enhancing the effectiveness and impact of the Board Member's leadership. Anjos's strategic insight and operational expertise are crucial for advancing Boehringer Ingelheim's mission to develop innovative medicines for human health.
Explore Leadership Teams in Manufacturing
Unither Pharmaceuticals is a global contract development and manufacturing organization (CDMO) specializing in the production of single-dose liquid pharmaceuticals and sterile unit-dose formats for the pharmaceutical and consumer healthcare industries. The company is recognized as a world leader in blow-fill-seal technology, an advanced aseptic manufacturing process that forms, fills, and seals plastic containers in a continuous automated operation, ensuring high levels of sterility and product integrity. Unither's expertise encompasses the development and manufacturing of various liquid dosage forms including oral solutions, suspensions, nasal sprays, eye drops, and other sterile and non-sterile pharmaceutical products delivered in innovative single-dose formats. The company serves a diverse client base of pharmaceutical companies, biotechnology firms, and consumer health brands, providing comprehensive services from formulation development and clinical trial manufacturing to commercial-scale production and packaging. With manufacturing facilities strategically located across multiple continents including Europe and North America, Unither maintains strict quality standards and regulatory compliance with international pharmaceutical guidelines including FDA and EMA requirements. The company emphasizes innovation in drug delivery systems, patient convenience, and sustainability while helping clients bring their pharmaceutical products to market efficiently through its specialized manufacturing capabilities and technical expertise in unit-dose liquid formulations.
Company Leadership HH
JK
MC
MB
Tilray was established in 2018 in British Columbia, Canada. They specialize in the research, cultivation, production and distribution of medical cannabis and cannabinoids.
Company Leadership AF
SS
Eurofarma is a pharmaceutical company that offers a diverse range of products including prescription medications, generics, oncology treatments, hospital care products, personal care items, and nutritional supplements. Their services are aimed at healthcare professionals, consumers, pharmacies, and B2B clients across various countries in Latin America. The company is committed to sustainability and innovation, actively engaging in clinical research and development. With over 50 years in the industry, Eurofarma focuses on improving health and wellness while maintaining a strong corporate governance framework.
Company Leadership MB
ET
FD
BS
CSPC Pharmaceutical Group Ltd. is an investment holding company, which is engaged in the manufacturing and selling of pharmaceutical products. It operates through the following business segments: Finished Drugs, Antibiotics, Vitamin C, Caffeine and Others. The company was founded on August 21, 1997 and is headquartered in Hong Kong.
Company Leadership CD
CL
CW
QW
Frequently Asked Questions Regarding Boehringer Ingelheim Top Executives and Leadership Team
